Elanco Animal Health (ELAN) Non Operating Income (2017 - 2024)
Elanco Animal Health (ELAN) posted Non Operating Income of -$1.0 million for Q3 2024, up 50.0% sequentially from -$2.0 million in Q2 2024, and up 88.89% YoY from -$529411.8 in Q4 2023.
Elanco Animal Health (ELAN) Non Operating Income (2017 - 2024) Analysis & Trends
Elanco Animal Health has reported Non Operating Income for 8 years, with the latest figure at -$1.0 million in Q3 2024.
- Quarterly Non Operating Income rose 88.89% year-over-year to -$1.0 million in Q3 2024, while the trailing twelve-month figure through Sep 2024 was -$46.0 million (up 25.81% YoY) and the FY2023 annual result came in at -$75.0 million, down 134.38% from the prior year.
- Non Operating Income grew to -$1.0 million in Q3 2024 per ELAN's latest filing, from -$2.0 million in the prior quarter.
- Over five years, Non Operating Income peaked at $115.0 million in Q3 2020 and troughed at -$34.0 million in Q4 2023.
- A 5-year average of $3.0 million and a median of -$5.0 million in 2022 frame the typical range for Non Operating Income.
- The sharpest annual moves came in 2020 and 2022: Non Operating Income soared 1330.77% in 2020, then tumbled 800.0% in 2022.
- Over 5 years, Non Operating Income stood at $16.0 million in 2020, then plunged by 81.25% to $3.0 million in 2021, then sank by 800.0% to -$21.0 million in 2022, then plunged by 61.9% to -$34.0 million in 2023, then surged by 97.06% to -$1.0 million in 2024.
- According to Business Quant data, Non Operating Income over the past three periods registered -$1.0 million, -$2.0 million, and -$9.0 million for Q3 2024, Q2 2024, and Q1 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.80 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.05 Bn | 39.39 Bn | 2.15 Bn | -224.00 Mn |
| 3 | Zoetis | 31.51 Bn | 29.84 Bn | 1.05 Bn | 5.00 Mn |
| 4 | Takeda Pharmaceutical | 28.70 Bn | 22.90 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 41.90 Mn |
| 6 | Viatris | 18.83 Bn | 17.95 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 10.70 Mn |
| 8 | Elanco Animal Health | 12.06 Bn | 11.53 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Alkermes | 8.27 Bn | 7.61 Bn | 397.90 Mn | -20.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -1.00 Mn |
| Jun 30, 2024 | -2.00 Mn |
| Mar 31, 2024 | -9.00 Mn |
| Dec 31, 2023 | -34.00 Mn |
| Sep 30, 2023 | -9.00 Mn |
| Jun 30, 2023 | -23.00 Mn |
| Mar 31, 2023 | -9.00 Mn |
| Dec 31, 2022 | -21.00 Mn |
| Sep 30, 2022 | -8.00 Mn |
| Jun 30, 2022 | 6.00 Mn |
| Mar 31, 2022 | -9.00 Mn |
| Dec 31, 2021 | 3.00 Mn |
| Sep 30, 2021 | -11.00 Mn |
| Jun 30, 2021 | 3.00 Mn |
| Dec 31, 2020 | 16.00 Mn |
| Sep 30, 2020 | 115.00 Mn |
| Jun 30, 2020 | 48.00 Mn |
| Mar 31, 2020 | -1.00 Mn |
| Dec 31, 2019 | -6.90 Mn |
| Sep 30, 2019 | -14.60 Mn |